Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.
复制标题
DOI:
10.1371/journal.pone.0001122
复制
发表时间:
2007-11-07
期刊:
影响因子:
3.7
通讯作者:
Masucci MG
中科院分区:
文献类型:
--
作者:
Li J;Zeng XH;Mo HY;Rolén U;Gao YF;Zhang XS;Chen QY;Zhang L;Zeng MS;Li MZ;Huang WL;Wang XN;Zeng YX;Masucci MG
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV) associated malignancy with high prevalence in Southern Chinese. In order to assess whether defects of EBV-specific immunity may contribute to the tumor, the phenotype and function of circulating T-cells and tumor infiltrating lymphocytes (TILs) were investigated in untreated NPC patients. Circulating naïve CD3+CD45RA+ and CD4+CD25− cells were decreased, while activated CD4+CD25+ T-cells and CD3−CD16+ NK-cells were increased in patients compared to healthy donors. The frequency of T-cells recognizing seven HLA-A2 restricted epitopes in LMP1 and LMP2 was lower in the patients and remained low after stimulation with autologous EBV-carrying cells. TILs expanded in low doses of IL-2 exhibited an increase of CD3+CD4+, CD3+CD45RO+ and CD4+CD25+ cells and 2 to 5 fold higher frequency of LMP1 and LMP2 tetramer positive cells compared to peripheral blood. EBV-specific cytotoxicity could be reactivated from the blood of most patients, whereas the TILs lacked cytotoxic activity and failed to produce IFNγ upon specific stimulation. Thus, EBV-specific rejection responses appear to be functionally inactivated at the tumor site in NPC.
登录
查看更多内容
影响因子:
5.4
作者:
Brooks, JM;Croom-Carter, DSG;Rickinson, AB
通讯作者:
Rickinson, AB
影响因子:
82.9
作者:
Heslop, HE;Ng, CYC;Rooney, CM
通讯作者:
Rooney, CM
影响因子:
64.8
作者:
LEVITSKAYA, J;CORAM, M;MASUCCI, MG
通讯作者:
MASUCCI, MG
影响因子:
2.2
作者:
Favre, N;Bordmann, G;Rudin, W
通讯作者:
Rudin, W
影响因子:
20.3
作者:
Herbst, H;Foss, HD;Stein, H
通讯作者:
Stein, H